NEW YORK (GenomeWeb News) – Optibrium and Molecular Networks today said that they will share complementary technology platforms for the drug discovery market.

The collaboration will integrate Molecular Networks' 3D structure generator, Corina, into Optibrium's StarDrop, a platform for guiding compound selection and design.

According to the firms, Corina is used within StarDrop's predictive P450 metabolism models, which identify metabolic liabilities of candidate molecules against the major cytochrome P450 enzymes.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Sometimes genetic tests give inconclusive results and provide little reassurance to patients, the Associated Press reports.

Vox wonders whether gene-editing crops will be viewed similarly as genetically modified organisms of if people will give them a try.

In Science this week: research regulation and reporting requirement reform, and more.

With H3Africa, Charles Rotimi has been working to bolster the representation of African participants and African researchers in genomics, Newsweek reports.